Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 15572713)

1.

Vitamin K deficiency and hepatocellular carcinoma.

Piquet MA, Hourmand-Ollivier I, Dao T.

JAMA. 2004 Dec 1;292(21):2580-1; author reply 2581. No abstract available.

PMID:
15572713
2.

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S, Nishiguchi S.

JAMA. 2004 Jul 21;292(3):358-61.

PMID:
15265851
3.

Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.

Kojima K, Tamano M, Akima T, Hashimoto T, Kuniyoshi T, Maeda C, Majima Y, Kusano K, Murohisa T, Iijima M, Hiraishi H.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1264-7.

PMID:
21410069
4.

[Screening of hepatocellular carcinoma in patients with liver cirrhosis].

Pateron D, Ganne N, Beaugrand M.

Ann Chir. 1993;47(3):203-5. Review. French. No abstract available.

PMID:
7687419
5.

[What is the value of systematic screening of hepatocellular carcinomas in patients with liver cirrhosis?].

Pateron D.

Gastroenterol Clin Biol. 1992;16(11):908-9. French. No abstract available.

PMID:
1336468
6.

Pleiotropic actions of vitamin K: protector of bone health and beyond?

Kaneki M, Hosoi T, Ouchi Y, Orimo H.

Nutrition. 2006 Jul-Aug;22(7-8):845-52. Review.

PMID:
16815498
7.

Screening of hepatocellular carcinoma in French patients.

Durand F, Buffet C, Pelletier G, Hagege H, Ink O, Etienne JP.

Dig Dis Sci. 1995 Mar;40(3):706-7. No abstract available.

PMID:
7895568
8.

[Prevention of hepatocellular carcinogenesis by interferon].

Ikeda K.

Nihon Rinsho. 2001 Oct;59 Suppl 6:755-63. Review. Japanese. No abstract available.

PMID:
11762051
9.

[Sho-saiko-to].

Oka H.

Nihon Rinsho. 2001 Oct;59 Suppl 6:774-8. Review. Japanese. No abstract available.

PMID:
11762055
10.

Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.

Poon RT.

Hepatology. 2011 Sep 2;54(3):757-9. doi: 10.1002/hep.24569. No abstract available.

PMID:
21793027
11.

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.

Hessheimer AJ, Forner A, Varela M, Bruix J.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1239-44. doi: 10.1097/MEG.0b013e32833aa19b.

PMID:
20505515
12.

Coffee, liver enzymes, cirrhosis and liver cancer.

La Vecchia C.

J Hepatol. 2005 Apr;42(4):444-6. Epub 2005 Jan 21. Review. No abstract available.

PMID:
15763323
13.

Interferon and hepatocellular carcinoma.

Andreone P, Cursaro C, Gramenzi A, Trevisani F, Gasbarrini G, Bernardi M.

Lancet. 1996 Jan 20;347(8995):195. No abstract available.

PMID:
8544566
14.

Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.

Zhong YD, Yang YF.

Hepatology. 2008 Oct;48(4):1348; author reply 1348. doi: 10.1002/hep.22492. No abstract available.

PMID:
18792394
15.

Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.

Chen TH, Chiu SY.

Hepatology. 2008 Oct;48(4):1348-9. doi: 10.1002/hep.22530. No abstract available.

PMID:
18792397
16.

Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.

Siegel AB, El-Serag HB.

Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):493-5. doi: 10.1586/17474124.2013.814884. No abstract available.

17.

[Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].

Nishiguchi S, Kubo S, Shiomi S.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):600-4. Review. Japanese. No abstract available.

PMID:
15359868
18.

[Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].

Yoshida H, Omata M.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):463-6. Review. Japanese. No abstract available.

PMID:
15359842
19.

[Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].

Trinchet JC, Alperovitch A, Bedossa P, Degos F, Hainaut P, Beers BV.

Bull Cancer. 2009 Jan;96(1):35-43. doi: 10.1684/bdc.2009.0791. Review. French.

PMID:
19211358
20.

[Clinical application of vitamin K for hepatocellular carcinoma].

Mizuta T, Ozaki I.

Clin Calcium. 2007 Nov;17(11):1693-9. Review. Japanese.

PMID:
17982189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk